YungKhai personal page - To The Moon

YungKhai

YungKhai

No personal profile

56Follow

29Followers

0Topic

0Badge

2023-11-14

$Nasdaq100 Bull 3X ETF(TQQQ)$ up

2023-11-09

$NASDAQ(.IXIC)$ Bullish predicted

2023-07-28

$Tiger Brokers(TIGR)$ where can ger tigers gpt information?

2023-03-24

$NASDAQ(.IXIC)$ downBearishdown due 25pt

2023-03-14

$NASDAQ(.IXIC)$ up today

2023-02-27

$NASDAQ(.IXIC)$ upBullishup Monday

2023-02-27

AEM share is low now chance to buy in

2023-02-24

$NASDAQ(.IXIC)$ Bullish

2023-02-15

$NASDAQ(.IXIC)$ againBullishagain

2023-02-13

$NASDAQ(.IXIC)$ upBullishup

2023-02-08

$NASDAQ(.IXIC)$ down

2023-02-07

$NASDAQ(.IXIC)$ upBullishup up

2023-02-06

$NASDAQ(.IXIC)$ sell

2023-02-06

$NASDAQ(.IXIC)$ dowm

2023-02-03

$NASDAQ(.IXIC)$ todayBearishtoday down

2023-02-01

$NASDAQ(.IXIC)$

2023-01-30

$NASDAQ(.IXIC)$

2023-01-13

$NASDAQ(.IXIC)$

2023-01-11

$NASDAQ(.IXIC)$

2023-01-09

$S&P 500(.SPX)$

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3581823025693276","uuid":"3581823025693276","gmtCreate":1618745405511,"gmtModify":1618928426956,"name":"YungKhai","pinyin":"yungkhai","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","hat":"https://static.tigerbbs.com/7b75ce0c34afff716602792a5d0929dd","hatId":"shopping-c3edc01e31206bedfff9b5eecea7bb42","hatName":"2023 New Year ","vip":1,"status":2,"fanSize":29,"headSize":56,"tweetSize":134,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.14","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"f00de38e20574ad1abf55a15966547c8-4","templateUuid":"f00de38e20574ad1abf55a15966547c8","name":"Average winning trade","description":"Top 10%","bigImgUrl":"https://community-static.tradeup.com/news/5d4a486b5707ca641782b8afa4d3261e","smallImgUrl":"https://community-static.tradeup.com/news/9d61ed9b62f2e13f9335a3de3bd18529","grayImgUrl":"https://community-static.tradeup.com/news/320fb40401f70873e9d982813fe82344","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5200},{"badgeId":"23f878ed27704312ae41c7f17e73b319-4","templateUuid":"23f878ed27704312ae41c7f17e73b319","name":"Annualised return","description":"Top 10%","bigImgUrl":"https://community-static.tradeup.com/news/15d4b5a89fa218ed3a35da1a05874cf6","smallImgUrl":"https://community-static.tradeup.com/news/16e2b28d75d7746886400fad4f4ec3e3","grayImgUrl":"https://community-static.tradeup.com/news/6f578d36f80e1a3d9c705f395e522048","redirectLinkEnabled":0,"redirectLink":"https://www.tigerbrokers.com.sg/activity/market/2023/stock-contest?adcode=StockContest2023","hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.09.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":5300},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.27%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":7,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.00%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":241423022792936,"gmtCreate":1699969572790,"gmtModify":1699969717396,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TQQQ\">$Nasdaq100 Bull 3X ETF(TQQQ)$&nbsp;</a><v-v data-views=\"1\"></v-v>up","listText":"<a href=\"https://ttm.financial/S/TQQQ\">$Nasdaq100 Bull 3X ETF(TQQQ)$&nbsp;</a><v-v data-views=\"1\"></v-v>up","text":"$Nasdaq100 Bull 3X ETF(TQQQ)$ up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/241423022792936","isVote":1,"tweetType":1,"viewCount":208,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":239626800513104,"gmtCreate":1699539539910,"gmtModify":1699539543424,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>Bullish predicted&nbsp;","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>Bullish predicted&nbsp;","text":"$NASDAQ(.IXIC)$ Bullish predicted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/239626800513104","isVote":1,"tweetType":1,"viewCount":460,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":202844441149656,"gmtCreate":1690551847184,"gmtModify":1690551850067,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ </a>&nbsp;where can ger tigers gpt information?&nbsp;","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ </a>&nbsp;where can ger tigers gpt information?&nbsp;","text":"$Tiger Brokers(TIGR)$ where can ger tigers gpt information?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/202844441149656","isVote":1,"tweetType":1,"viewCount":795,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3563421686188310","authorId":"3563421686188310","name":"Hopehope赋予希望","avatar":"https://community-static.tradeup.com/news/46495f44529967f5d3b4d03a47167f5b","crmLevel":9,"crmLevelSwitch":1,"idStr":"3563421686188310","authorIdStr":"3563421686188310"},"content":"go to search button on the top right. then a tiger gpt app will appear at bottom right","text":"go to search button on the top right. then a tiger gpt app will appear at bottom right","html":"go to search button on the top right. then a tiger gpt app will appear at bottom right"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9943706282,"gmtCreate":1679671948347,"gmtModify":1679671951777,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>downBearishdown due 25pt","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>downBearishdown due 25pt","text":"$NASDAQ(.IXIC)$ downBearishdown due 25pt","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943706282","isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9949491559,"gmtCreate":1678802519972,"gmtModify":1678802523381,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>up today","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>up today","text":"$NASDAQ(.IXIC)$ up today","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9949491559","isVote":1,"tweetType":1,"viewCount":439,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9957454236,"gmtCreate":1677509679825,"gmtModify":1677509682868,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>upBullishup Monday&nbsp;","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>upBullishup Monday&nbsp;","text":"$NASDAQ(.IXIC)$ upBullishup Monday","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957454236","isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9957461633,"gmtCreate":1677498342223,"gmtModify":1677498346190,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"AEM share is low now chance to buy in","listText":"AEM share is low now chance to buy in","text":"AEM share is low now chance to buy in","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957461633","isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9957853133,"gmtCreate":1677169876022,"gmtModify":1677169878635,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>Bullish&nbsp;","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>Bullish&nbsp;","text":"$NASDAQ(.IXIC)$ Bullish","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957853133","isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9954562199,"gmtCreate":1676471306411,"gmtModify":1676471311205,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>againBullishagain&nbsp;","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>againBullishagain&nbsp;","text":"$NASDAQ(.IXIC)$ againBullishagain","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9954562199","isVote":1,"tweetType":1,"viewCount":326,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9954691709,"gmtCreate":1676296038902,"gmtModify":1676296041780,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>upBullishup&nbsp;","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>upBullishup&nbsp;","text":"$NASDAQ(.IXIC)$ upBullishup","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9954691709","isVote":1,"tweetType":1,"viewCount":295,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9954028096,"gmtCreate":1675858418515,"gmtModify":1675858420314,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>down","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>down","text":"$NASDAQ(.IXIC)$ down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9954028096","isVote":1,"tweetType":1,"viewCount":366,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955726750,"gmtCreate":1675780984671,"gmtModify":1675780987756,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>upBullishup up","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>upBullishup up","text":"$NASDAQ(.IXIC)$ upBullishup up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955726750","isVote":1,"tweetType":1,"viewCount":148,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955425776,"gmtCreate":1675693711595,"gmtModify":1675693714449,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>sell","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>sell","text":"$NASDAQ(.IXIC)$ sell","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955425776","isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955425540,"gmtCreate":1675693379080,"gmtModify":1675693381617,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>dowm","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>dowm","text":"$NASDAQ(.IXIC)$ dowm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955425540","isVote":1,"tweetType":1,"viewCount":106,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955296365,"gmtCreate":1675432008858,"gmtModify":1676539002431,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>todayBearishtoday down&nbsp;","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>todayBearishtoday down&nbsp;","text":"$NASDAQ(.IXIC)$ todayBearishtoday down","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955296365","isVote":1,"tweetType":1,"viewCount":192,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955139838,"gmtCreate":1675261535325,"gmtModify":1676538988136,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"1\"></v-v>","text":"$NASDAQ(.IXIC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955139838","isVote":1,"tweetType":1,"viewCount":126,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9955063389,"gmtCreate":1675079854542,"gmtModify":1676538974684,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>","text":"$NASDAQ(.IXIC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9955063389","isVote":1,"tweetType":1,"viewCount":94,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9958938090,"gmtCreate":1673607302211,"gmtModify":1676538863756,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>","text":"$NASDAQ(.IXIC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9958938090","isVote":1,"tweetType":1,"viewCount":82,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9951800766,"gmtCreate":1673439326956,"gmtModify":1676538836748,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://ttm.financial/S/.IXIC\">$NASDAQ(.IXIC)$&nbsp;</a><v-v data-views=\"0\"></v-v>","text":"$NASDAQ(.IXIC)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9951800766","isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9953268327,"gmtCreate":1673269348869,"gmtModify":1676538808515,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/.SPX\">$S&amp;P 500(.SPX)$&nbsp;</a><v-v data-views=\"0\"></v-v>","listText":"<a href=\"https://ttm.financial/S/.SPX\">$S&amp;P 500(.SPX)$&nbsp;</a><v-v data-views=\"0\"></v-v>","text":"$S&P 500(.SPX)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9953268327","isVote":1,"tweetType":1,"viewCount":114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":896739916,"gmtCreate":1628604506035,"gmtModify":1676529794764,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>&nbsp;Will reach 300 when FDA approve.","listText":"<a href=\"https://laohu8.com/S/NVAX\">$Novavax(NVAX)$</a>&nbsp;Will reach 300 when FDA approve.","text":"$Novavax(NVAX)$ Will reach 300 when FDA approve.","images":[{"img":"https://static.tigerbbs.com/520ab10c2c2f51ca112890af7cc3eac1","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/896739916","isVote":1,"tweetType":1,"viewCount":614,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9032445027,"gmtCreate":1647434262950,"gmtModify":1676534229290,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp;will back to 21?","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp;will back to 21?","text":"$Tiger Brokers(TIGR)$ will back to 21?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9032445027","isVote":1,"tweetType":1,"viewCount":889,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836664065,"gmtCreate":1629477544057,"gmtModify":1676530055569,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp;will back to 17 dollars On next week?&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp;will back to 17 dollars On next week?&nbsp;","text":"$Tiger Brokers(TIGR)$ will back to 17 dollars On next week?","images":[{"img":"https://static.tigerbbs.com/cf3066d2b01900d3330ae4dc2779bd17","width":"1080","height":"3561"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/836664065","isVote":1,"tweetType":1,"viewCount":1566,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":103905177,"gmtCreate":1619741583099,"gmtModify":1704271604766,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>&nbsp;The chart is for BioNTech for next 2 week share price. Up to 254.?","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>&nbsp;The chart is for BioNTech for next 2 week share price. Up to 254.?","text":"$BioNTech SE(BNTX)$ The chart is for BioNTech for next 2 week share price. Up to 254.?","images":[{"img":"https://static.tigerbbs.com/2ba2b7af48eca69d18af67d44c7b7d15","width":"1080","height":"757"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":2,"link":"https://ttm.financial/post/103905177","isVote":1,"tweetType":1,"viewCount":328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":151062111,"gmtCreate":1625058515033,"gmtModify":1703735032069,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Moving another step closer to World Health Organisation (WHO) approval, the rolling data of ‘made in India’ Covid-19 vaccine Covaxin will be starting in July. This has come after the pre-submission meeting held on June 23 with Bharat Biotech.The status of Covid-19 vaccines within the EUL/PQ (emergency use listing/prequalification) evaluation process was updated on Tuesday by WHO in its latest guidance document.Emergency Use Listing (EUL) is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies, WHO guidelines said.Stating that its Covid-19 vaccine Covaxin adheres to international standards, Bharat Biotech’s joint managing director Suchitra Ella on Tuesday said externa","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Moving another step closer to World Health Organisation (WHO) approval, the rolling data of ‘made in India’ Covid-19 vaccine Covaxin will be starting in July. This has come after the pre-submission meeting held on June 23 with Bharat Biotech.The status of Covid-19 vaccines within the EUL/PQ (emergency use listing/prequalification) evaluation process was updated on Tuesday by WHO in its latest guidance document.Emergency Use Listing (EUL) is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies, WHO guidelines said.Stating that its Covid-19 vaccine Covaxin adheres to international standards, Bharat Biotech’s joint managing director Suchitra Ella on Tuesday said externa","text":"$Histogenics(OCGN)$Moving another step closer to World Health Organisation (WHO) approval, the rolling data of ‘made in India’ Covid-19 vaccine Covaxin will be starting in July. This has come after the pre-submission meeting held on June 23 with Bharat Biotech.The status of Covid-19 vaccines within the EUL/PQ (emergency use listing/prequalification) evaluation process was updated on Tuesday by WHO in its latest guidance document.Emergency Use Listing (EUL) is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies, WHO guidelines said.Stating that its Covid-19 vaccine Covaxin adheres to international standards, Bharat Biotech’s joint managing director Suchitra Ella on Tuesday said externa","images":[{"img":"https://static.tigerbbs.com/baae8ce3d31dcb8ac941c6f21f2c4688","width":"1080","height":"3300"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/151062111","isVote":1,"tweetType":1,"viewCount":3400,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3547151922080793","authorId":"3547151922080793","name":"年糕小豆汤","avatar":"https://static.tigerbbs.com/2d25e73531f483877f22b6edd44af153","crmLevel":2,"crmLevelSwitch":0,"idStr":"3547151922080793","authorIdStr":"3547151922080793"},"content":"After this authorization is passed, can you sell drugs in the United States and Canada","text":"After this authorization is passed, can you sell drugs in the United States and Canada","html":"After this authorization is passed, can you sell drugs in the United States and Canada"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":188093581,"gmtCreate":1623415106844,"gmtModify":1704202974192,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>US FDA rejects emergency use approval for Bharat Biotech's Covaxin so&nbsp;down almost 30%.What will happen today? Will continue down?? Or up back to the previous value?&nbsp;","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>US FDA rejects emergency use approval for Bharat Biotech's Covaxin so&nbsp;down almost 30%.What will happen today? Will continue down?? Or up back to the previous value?&nbsp;","text":"$Histogenics(OCGN)$US FDA rejects emergency use approval for Bharat Biotech's Covaxin so down almost 30%.What will happen today? Will continue down?? Or up back to the previous value?","images":[{"img":"https://static.tigerbbs.com/c767fa42173db369cbdec61c1bd248e7","width":"1080","height":"2892"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/188093581","isVote":1,"tweetType":1,"viewCount":1874,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3554857419065509","authorId":"3554857419065509","name":"R0B1N","avatar":"https://static.tigerbbs.com/6b2f48f96ea98fde36c514c6227fb5f3","crmLevel":2,"crmLevelSwitch":0,"idStr":"3554857419065509","authorIdStr":"3554857419065509"},"content":"Please do not post news that are fake. They are advised to go directly for BLA which is FDA approval path, which Moderna and Pzifer is working on.","text":"Please do not post news that are fake. They are advised to go directly for BLA which is FDA approval path, which Moderna and Pzifer is working on.","html":"Please do not post news that are fake. They are advised to go directly for BLA which is FDA approval path, which Moderna and Pzifer is working on."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":138539051,"gmtCreate":1621948675673,"gmtModify":1704364950552,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Buy in yesterday.&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>Buy in yesterday.&nbsp;","text":"$Tiger Brokers(TIGR)$Buy in yesterday.","images":[{"img":"https://static.tigerbbs.com/15d66654c02b3cfb3063f8d687452af5","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":14,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/138539051","isVote":1,"tweetType":1,"viewCount":290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117585784,"gmtCreate":1623151427248,"gmtModify":1704197115777,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp;What happen to tiger? Pre market down 10%.Good time to buy in?&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp;What happen to tiger? Pre market down 10%.Good time to buy in?&nbsp;","text":"$Tiger Brokers(TIGR)$ What happen to tiger? Pre market down 10%.Good time to buy in?","images":[{"img":"https://static.tigerbbs.com/4f29f57bbfe7bc72f48212c7de34d27f","width":"1080","height":"2964"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/117585784","isVote":1,"tweetType":1,"viewCount":2988,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":119296385,"gmtCreate":1622547350747,"gmtModify":1704186045974,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LEDS\">$SemiLEDs(LEDS)$</a>&nbsp;High trading this share. Will it up to 23 dollars?&nbsp;","listText":"<a href=\"https://laohu8.com/S/LEDS\">$SemiLEDs(LEDS)$</a>&nbsp;High trading this share. Will it up to 23 dollars?&nbsp;","text":"$SemiLEDs(LEDS)$ High trading this share. Will it up to 23 dollars?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/119296385","isVote":1,"tweetType":1,"viewCount":1429,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3571443113106947","authorId":"3571443113106947","name":"xtsc","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"3571443113106947","authorIdStr":"3571443113106947"},"content":"I don't dare to think of going up that high","text":"I don't dare to think of going up that high","html":"I don't dare to think of going up that high"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819570366,"gmtCreate":1630080556855,"gmtModify":1676530220741,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>&nbsp;will back 100?&nbsp;","listText":"<a href=\"https://laohu8.com/S/SAVA\">$Cassava Sciences Inc(SAVA)$</a>&nbsp;will back 100?&nbsp;","text":"$Cassava Sciences Inc(SAVA)$ will back 100?","images":[{"img":"https://static.tigerbbs.com/75e92f4142e46a7599105e9e6ad70878","width":"1080","height":"3444"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/819570366","isVote":1,"tweetType":1,"viewCount":473,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":805714168,"gmtCreate":1627906529154,"gmtModify":1703497586668,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>&nbsp;Will continues up","listText":"<a href=\"https://laohu8.com/S/MRNA\">$Moderna, Inc.(MRNA)$</a>&nbsp;Will continues up","text":"$Moderna, Inc.(MRNA)$ Will continues up","images":[{"img":"https://static.tigerbbs.com/ba2004f606b6ff8b368db56a36999058","width":"1080","height":"3588"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":1,"link":"https://ttm.financial/post/805714168","isVote":1,"tweetType":1,"viewCount":611,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":152996678,"gmtCreate":1625250692794,"gmtModify":1703739430654,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>TAIPEI: Terry Gou, the billionaire founder of Taiwan's Foxconn, and TSMC reached initial agreements to buy 5 million doses each of BioNTech SE's COVID-19 vaccine on Friday (Jul 2), three sources with knowledge of the situation told Reuters.Taiwan's government has tried for months to buy the shots directly from Germany's BioNTech and has blamed China, which claims the self-ruled island as its own territory, for nixing a deal the two sides were due to sign earlier this year.","listText":"<a href=\"https://laohu8.com/S/BNTX\">$BioNTech SE(BNTX)$</a>TAIPEI: Terry Gou, the billionaire founder of Taiwan's Foxconn, and TSMC reached initial agreements to buy 5 million doses each of BioNTech SE's COVID-19 vaccine on Friday (Jul 2), three sources with knowledge of the situation told Reuters.Taiwan's government has tried for months to buy the shots directly from Germany's BioNTech and has blamed China, which claims the self-ruled island as its own territory, for nixing a deal the two sides were due to sign earlier this year.","text":"$BioNTech SE(BNTX)$TAIPEI: Terry Gou, the billionaire founder of Taiwan's Foxconn, and TSMC reached initial agreements to buy 5 million doses each of BioNTech SE's COVID-19 vaccine on Friday (Jul 2), three sources with knowledge of the situation told Reuters.Taiwan's government has tried for months to buy the shots directly from Germany's BioNTech and has blamed China, which claims the self-ruled island as its own territory, for nixing a deal the two sides were due to sign earlier this year.","images":[{"img":"https://static.tigerbbs.com/327e0dc96becbdb4c452e9c2d05b5152","width":"1080","height":"3324"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/152996678","isVote":1,"tweetType":1,"viewCount":960,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":801069503,"gmtCreate":1627474051802,"gmtModify":1703490621777,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XPEV\">$XPeng Inc.(XPEV)$</a>&nbsp;will return to 42?","listText":"<a href=\"https://laohu8.com/S/XPEV\">$XPeng Inc.(XPEV)$</a>&nbsp;will return to 42?","text":"$XPeng Inc.(XPEV)$ will return to 42?","images":[{"img":"https://static.tigerbbs.com/94725674fc590a69a07dad1d69b13869","width":"1080","height":"3809"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/801069503","isVote":1,"tweetType":1,"viewCount":485,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":159476112,"gmtCreate":1624978528436,"gmtModify":1703849401241,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>&nbsp;go to moon now","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>&nbsp;go to moon now","text":"$Histogenics(OCGN)$ go to moon now","images":[{"img":"https://static.tigerbbs.com/52285b0bfdbdd9f55f05d42ac9136630","width":"1080","height":"3201"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/159476112","isVote":1,"tweetType":1,"viewCount":504,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":122235752,"gmtCreate":1624622163076,"gmtModify":1703841929864,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Will gain to their 52week higher record?&nbsp;","listText":"<a href=\"https://laohu8.com/S/OCGN\">$Histogenics(OCGN)$</a>Will gain to their 52week higher record?&nbsp;","text":"$Histogenics(OCGN)$Will gain to their 52week higher record?","images":[{"img":"https://static.tigerbbs.com/b5ce9f6c1b0d1b664a83bfc1d0bd49ac","width":"1080","height":"3300"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/122235752","isVote":1,"tweetType":1,"viewCount":637,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":121986817,"gmtCreate":1624449567939,"gmtModify":1703837001328,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp;Happy&nbsp;7th Years Anniversary to Tiger Brokers.&nbsp;","listText":"<a href=\"https://laohu8.com/S/TIGR\">$Tiger Brokers(TIGR)$</a>&nbsp;Happy&nbsp;7th Years Anniversary to Tiger Brokers.&nbsp;","text":"$Tiger Brokers(TIGR)$ Happy 7th Years Anniversary to Tiger Brokers.","images":[{"img":"https://static.tigerbbs.com/769e88b41b5faaf613db66aa4b87675c","width":"1080","height":"3423"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/121986817","isVote":1,"tweetType":1,"viewCount":322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":117588296,"gmtCreate":1623151241615,"gmtModify":1704197111213,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>&nbsp;show position earnings hope to raise 10%~15%<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>&nbsp;still raise 5% on pre-market<a href=\"https://laohu8.com/S/LEDS\">$SemiLEDs(LEDS)$</a>&nbsp;was continues raise 5day.&nbsp;","listText":"<a href=\"https://laohu8.com/S/BB\">$BlackBerry(BB)$</a>&nbsp;show position earnings hope to raise 10%~15%<a href=\"https://laohu8.com/S/AMC\">$AMC Entertainment(AMC)$</a>&nbsp;still raise 5% on pre-market<a href=\"https://laohu8.com/S/LEDS\">$SemiLEDs(LEDS)$</a>&nbsp;was continues raise 5day.&nbsp;","text":"$BlackBerry(BB)$ show position earnings hope to raise 10%~15%$AMC Entertainment(AMC)$ still raise 5% on pre-market$SemiLEDs(LEDS)$ was continues raise 5day.","images":[{"img":"https://static.tigerbbs.com/585b7239f6becbfb4aca24887698b88b","width":"1080","height":"2892"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/117588296","isVote":1,"tweetType":1,"viewCount":901,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":378371606,"gmtCreate":1619006558005,"gmtModify":1704718170430,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/378371606","repostId":"2129829074","repostType":4,"repost":{"id":"2129829074","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1618979520,"share":"https://ttm.financial/m/news/2129829074?lang=&edition=fundamental","pubTime":"2021-04-21 12:32","market":"us","language":"en","title":"UiPath IPO: 5 things to know about the 'software robots' company valued at nearly $30 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2129829074","media":"Dow Jones","summary":"UiPath increased customers by 33% during pandemic by making automation software that is marketed toward employees without software-development knowledge or experience.UiPath Inc. is launching its initial public offering at a valuation close to what it received from venture-capital investors, with help from automation it cheerfully calls \"software robots.\". UiPath $$ makes software that helps automate business tasks, and sets itself apart from rivals by allowing employees without coding experienc","content":"<blockquote>UiPath increased customers by 33% during pandemic by making automation software that is marketed toward employees without software-development knowledge or experience.</blockquote><p>UiPath Inc. is launching its initial public offering at a valuation close to what it received from venture-capital investors, with help from automation it cheerfully calls \"software robots.\"</p><p>UiPath <a href=\"https://laohu8.com/S/PATH.UK\">$(PATH.UK)$</a> makes software that helps automate business tasks, and sets itself apart from rivals by allowing employees without coding experience to customize artificial-intelligence capabilities.</p><p>\"Traditional automation solutions intended to reduce this friction have generally been designed to be used by developers and engineers, rather than the employees directly involved in executing the actual work being automated,\" the company said in its filing with the Securities and Exchange Commission.</p><p>\"Our platform leverages the power of artificial intelligence, or AI, based computer vision to enable our software robots to perform a vast array of actions as a human would when executing business processes,\" the company said. \"These actions include, but are not limited to, logging into applications, extracting information from documents, moving folders, filling in forms, and updating information fields and databases.\"</p><p>Late Tuesday, UiPath priced its IPO at $56 a share, raising more than $1.3 billion and giving the company an initial market capitalization of $29.1 billion, which is less than the self-valuation of $35 billion  following a $750 million round of venture funding on Feb. 1. It's expected to begin trading Wednesday on the New York Stock Exchange under the ticker \"PATH.\"</p><p>UiPath originally filed for its IPO on March 26   have opted for a direct listing instead.</p><p>The New York-based company originally said it was registering up to 24.5 million shares, at a range of $43 to $50 a share, to raise up to $1.22 billion. On Monday, it hiked the range to between $52 and $54 a share  and increased the number of shares it planned to offer.</p><p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, J.P. Morgan, B of A Securities, Credit Suisse, Barclays, and Wells Fargo Securities are among the underwriters.</p><p><b>Here are five things to know about UiPath:</b></p><p><b>The 'humble' company notes rapid expansion</b></p><p>In the S-1, UiPath Chief Executive, Chairman and co-founder Daniel Dines wrote about his company having \"humility\" as a core value, in that it allows its developers to listen and adapt quickly to the needs of the customer. Founded in Bucharest, Romania, in 2005, the company was incorporated in Delaware six years ago after working its way up from \"10 people in an apartment in Romania,\" Dines wrote.</p><p>\"We went against the rules of perfecting the business model first in <a href=\"https://laohu8.com/S/AONE\">one</a> territory, and instead we rapidly expanded globally to the United States, Europe, and Asia simultaneously,\" the CEO wrote in a letter.</p><p>At a current annualized renewal run rate, or ARR, of $580 million, UiPath bills itself as \"<a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest-growing modern enterprise software companies ever.\" ARR is a metric often used by software-as-a-service companies to show how much revenue the company can expect based on subscriptions.</p><p>While UiPath notes International Data Corp. sees the automation software market at $17 billion in 2020, with an expected rise to $30 billion by 2024, the company said its \"fully automated enterprise\" software gives it a current market opportunity of more than $60 billion.</p><p><b>CEO holds most of the cards</b></p><p>Since 2015, UiPath has raised about $2 billion in eight funding rounds, according to Crunchbase. That funding doesn't appear to have bought much voting power in the company, though.</p><p>UiPath's Class B shares carry 35 votes, while Class A shares -- being offered in the IPO -- carry one vote. The S-1 filing revealed that CEO Dines holds 100% of the Class B shares and 6.5% of the Class A shares, for 88.1% of the voting power.</p><p>The only entity that comes close to that is venture-capital firm Accel, which began building its stake in 2017, and now claims about 101 million Class A shares, or 24% of those shares, for 3.1% of the voting power. Earlybird Management, with 9.5% of Class A shares, commands 1.2% of the votes.</p><p><b>The company has reined in expenses</b></p><p>For the fiscal year 2021 ended Jan. 30, the company booked $607.6 million in revenue for a loss of $92.4 million, compared with $336.2 million in revenue for a loss of $519.9 million in fiscal 2020. In 2018, UiPath reported fiscal 2019 revenue of $148.5 million and a loss of $261.6 million.</p><p>As revenue rose 81% for fiscal 2021, UiPath reduced sales and marketing costs by 21%, research and development costs by 16%, and general and administrative expenses by 10%.</p><p><b>No specific plans for the funds</b></p><p>If underwriters exercise all option for shares in the offering, UiPath expects to bring in net proceeds of about $1.34 billion, based on a $56 stock price. With about $357.7 million in ready cash on the books as of Jan. 31, the company isn't earmarking raised capital for any specific use.</p><p>\"As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to us from this offering,\" the company said in its April 19 filing. \"However, we currently intend to use the net proceeds we receive from this offering for general corporate purposes, including working capital, operating expenses, and capital expenditures.\"</p><p><b>COVID-19 boosted diverse customer base</b></p><p>As of Jan. 31, the company claimed having nearly 8,000 customers, with 63% of the those in the Fortune Global 500. About 1,000 of those customers account for more than $100,000 in ARR apiece, UiPath said. The company highlighted such customers as Adobe Inc. <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, Applied Materials Inc. <a href=\"https://laohu8.com/S/AMAT\">$(AMAT)$</a>, Chevron Corp. <a href=\"https://laohu8.com/S/CVX\">$(CVX)$</a>, Chipotle Mexican Grill Inc. <a href=\"https://laohu8.com/S/CMG\">$(CMG)$</a>, CrowdStrike Holdings Inc. <a href=\"https://laohu8.com/S/CRWD\">$(CRWD)$</a>, CVS Health Corp. <a href=\"https://laohu8.com/S/CVS\">$(CVS)$</a> and Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a>.</p><p>That's compared with the 700-or-so customers the company claimed in 2018.</p><p>The company's current customer base is spread out enough where one customer can't upset revenue significantly.  \"No customer or channel partner accounted for more than 10% of our revenue for the year-ended January 31, 2021,\" according to the S-1.</p><p>Meanwhile, the COVID-19 pandemic helped. On Jan. 31, 2020, the company said it had about 6,000 customers, so during the year of the pandemic alone, UiPath grew its number of customers by 33%.</p><p>\"As the pandemic persisted, global demand for automation continued to accelerate as automation became essential for business execution and performance in a remote working environment,\" UiPath said.</p><p>\"While the pandemic may have accelerated the adoption of automation, the need for organizations to address extraordinary cost pressures, preserve and grow revenue, and adapt to ever-evolving end-customer needs illustrates the durability of the demand for digital transformation and the resilience and power of automation in even the most challenging times,\" according to the company.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UiPath IPO: 5 things to know about the 'software robots' company valued at nearly $30 billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUiPath IPO: 5 things to know about the 'software robots' company valued at nearly $30 billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-04-21 12:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>UiPath increased customers by 33% during pandemic by making automation software that is marketed toward employees without software-development knowledge or experience.</blockquote><p>UiPath Inc. is launching its initial public offering at a valuation close to what it received from venture-capital investors, with help from automation it cheerfully calls \"software robots.\"</p><p>UiPath <a href=\"https://laohu8.com/S/PATH.UK\">$(PATH.UK)$</a> makes software that helps automate business tasks, and sets itself apart from rivals by allowing employees without coding experience to customize artificial-intelligence capabilities.</p><p>\"Traditional automation solutions intended to reduce this friction have generally been designed to be used by developers and engineers, rather than the employees directly involved in executing the actual work being automated,\" the company said in its filing with the Securities and Exchange Commission.</p><p>\"Our platform leverages the power of artificial intelligence, or AI, based computer vision to enable our software robots to perform a vast array of actions as a human would when executing business processes,\" the company said. \"These actions include, but are not limited to, logging into applications, extracting information from documents, moving folders, filling in forms, and updating information fields and databases.\"</p><p>Late Tuesday, UiPath priced its IPO at $56 a share, raising more than $1.3 billion and giving the company an initial market capitalization of $29.1 billion, which is less than the self-valuation of $35 billion  following a $750 million round of venture funding on Feb. 1. It's expected to begin trading Wednesday on the New York Stock Exchange under the ticker \"PATH.\"</p><p>UiPath originally filed for its IPO on March 26   have opted for a direct listing instead.</p><p>The New York-based company originally said it was registering up to 24.5 million shares, at a range of $43 to $50 a share, to raise up to $1.22 billion. On Monday, it hiked the range to between $52 and $54 a share  and increased the number of shares it planned to offer.</p><p><a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a>, J.P. Morgan, B of A Securities, Credit Suisse, Barclays, and Wells Fargo Securities are among the underwriters.</p><p><b>Here are five things to know about UiPath:</b></p><p><b>The 'humble' company notes rapid expansion</b></p><p>In the S-1, UiPath Chief Executive, Chairman and co-founder Daniel Dines wrote about his company having \"humility\" as a core value, in that it allows its developers to listen and adapt quickly to the needs of the customer. Founded in Bucharest, Romania, in 2005, the company was incorporated in Delaware six years ago after working its way up from \"10 people in an apartment in Romania,\" Dines wrote.</p><p>\"We went against the rules of perfecting the business model first in <a href=\"https://laohu8.com/S/AONE\">one</a> territory, and instead we rapidly expanded globally to the United States, Europe, and Asia simultaneously,\" the CEO wrote in a letter.</p><p>At a current annualized renewal run rate, or ARR, of $580 million, UiPath bills itself as \"<a href=\"https://laohu8.com/S/AONE.U\">one</a> of the fastest-growing modern enterprise software companies ever.\" ARR is a metric often used by software-as-a-service companies to show how much revenue the company can expect based on subscriptions.</p><p>While UiPath notes International Data Corp. sees the automation software market at $17 billion in 2020, with an expected rise to $30 billion by 2024, the company said its \"fully automated enterprise\" software gives it a current market opportunity of more than $60 billion.</p><p><b>CEO holds most of the cards</b></p><p>Since 2015, UiPath has raised about $2 billion in eight funding rounds, according to Crunchbase. That funding doesn't appear to have bought much voting power in the company, though.</p><p>UiPath's Class B shares carry 35 votes, while Class A shares -- being offered in the IPO -- carry one vote. The S-1 filing revealed that CEO Dines holds 100% of the Class B shares and 6.5% of the Class A shares, for 88.1% of the voting power.</p><p>The only entity that comes close to that is venture-capital firm Accel, which began building its stake in 2017, and now claims about 101 million Class A shares, or 24% of those shares, for 3.1% of the voting power. Earlybird Management, with 9.5% of Class A shares, commands 1.2% of the votes.</p><p><b>The company has reined in expenses</b></p><p>For the fiscal year 2021 ended Jan. 30, the company booked $607.6 million in revenue for a loss of $92.4 million, compared with $336.2 million in revenue for a loss of $519.9 million in fiscal 2020. In 2018, UiPath reported fiscal 2019 revenue of $148.5 million and a loss of $261.6 million.</p><p>As revenue rose 81% for fiscal 2021, UiPath reduced sales and marketing costs by 21%, research and development costs by 16%, and general and administrative expenses by 10%.</p><p><b>No specific plans for the funds</b></p><p>If underwriters exercise all option for shares in the offering, UiPath expects to bring in net proceeds of about $1.34 billion, based on a $56 stock price. With about $357.7 million in ready cash on the books as of Jan. 31, the company isn't earmarking raised capital for any specific use.</p><p>\"As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to us from this offering,\" the company said in its April 19 filing. \"However, we currently intend to use the net proceeds we receive from this offering for general corporate purposes, including working capital, operating expenses, and capital expenditures.\"</p><p><b>COVID-19 boosted diverse customer base</b></p><p>As of Jan. 31, the company claimed having nearly 8,000 customers, with 63% of the those in the Fortune Global 500. About 1,000 of those customers account for more than $100,000 in ARR apiece, UiPath said. The company highlighted such customers as Adobe Inc. <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, Applied Materials Inc. <a href=\"https://laohu8.com/S/AMAT\">$(AMAT)$</a>, Chevron Corp. <a href=\"https://laohu8.com/S/CVX\">$(CVX)$</a>, Chipotle Mexican Grill Inc. <a href=\"https://laohu8.com/S/CMG\">$(CMG)$</a>, CrowdStrike Holdings Inc. <a href=\"https://laohu8.com/S/CRWD\">$(CRWD)$</a>, CVS Health Corp. <a href=\"https://laohu8.com/S/CVS\">$(CVS)$</a> and Uber Technologies Inc. <a href=\"https://laohu8.com/S/UBER\">$(UBER)$</a>.</p><p>That's compared with the 700-or-so customers the company claimed in 2018.</p><p>The company's current customer base is spread out enough where one customer can't upset revenue significantly.  \"No customer or channel partner accounted for more than 10% of our revenue for the year-ended January 31, 2021,\" according to the S-1.</p><p>Meanwhile, the COVID-19 pandemic helped. On Jan. 31, 2020, the company said it had about 6,000 customers, so during the year of the pandemic alone, UiPath grew its number of customers by 33%.</p><p>\"As the pandemic persisted, global demand for automation continued to accelerate as automation became essential for business execution and performance in a remote working environment,\" UiPath said.</p><p>\"While the pandemic may have accelerated the adoption of automation, the need for organizations to address extraordinary cost pressures, preserve and grow revenue, and adapt to ever-evolving end-customer needs illustrates the durability of the demand for digital transformation and the resilience and power of automation in even the most challenging times,\" according to the company.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRCT":"Cricut, Inc.","TERN":"Terns Pharmaceuticals, Inc.","PATH":"UiPath"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2129829074","content_text":"UiPath increased customers by 33% during pandemic by making automation software that is marketed toward employees without software-development knowledge or experience.UiPath Inc. is launching its initial public offering at a valuation close to what it received from venture-capital investors, with help from automation it cheerfully calls \"software robots.\"UiPath $(PATH.UK)$ makes software that helps automate business tasks, and sets itself apart from rivals by allowing employees without coding experience to customize artificial-intelligence capabilities.\"Traditional automation solutions intended to reduce this friction have generally been designed to be used by developers and engineers, rather than the employees directly involved in executing the actual work being automated,\" the company said in its filing with the Securities and Exchange Commission.\"Our platform leverages the power of artificial intelligence, or AI, based computer vision to enable our software robots to perform a vast array of actions as a human would when executing business processes,\" the company said. \"These actions include, but are not limited to, logging into applications, extracting information from documents, moving folders, filling in forms, and updating information fields and databases.\"Late Tuesday, UiPath priced its IPO at $56 a share, raising more than $1.3 billion and giving the company an initial market capitalization of $29.1 billion, which is less than the self-valuation of $35 billion  following a $750 million round of venture funding on Feb. 1. It's expected to begin trading Wednesday on the New York Stock Exchange under the ticker \"PATH.\"UiPath originally filed for its IPO on March 26   have opted for a direct listing instead.The New York-based company originally said it was registering up to 24.5 million shares, at a range of $43 to $50 a share, to raise up to $1.22 billion. On Monday, it hiked the range to between $52 and $54 a share  and increased the number of shares it planned to offer.Morgan Stanley, J.P. Morgan, B of A Securities, Credit Suisse, Barclays, and Wells Fargo Securities are among the underwriters.Here are five things to know about UiPath:The 'humble' company notes rapid expansionIn the S-1, UiPath Chief Executive, Chairman and co-founder Daniel Dines wrote about his company having \"humility\" as a core value, in that it allows its developers to listen and adapt quickly to the needs of the customer. Founded in Bucharest, Romania, in 2005, the company was incorporated in Delaware six years ago after working its way up from \"10 people in an apartment in Romania,\" Dines wrote.\"We went against the rules of perfecting the business model first in one territory, and instead we rapidly expanded globally to the United States, Europe, and Asia simultaneously,\" the CEO wrote in a letter.At a current annualized renewal run rate, or ARR, of $580 million, UiPath bills itself as \"one of the fastest-growing modern enterprise software companies ever.\" ARR is a metric often used by software-as-a-service companies to show how much revenue the company can expect based on subscriptions.While UiPath notes International Data Corp. sees the automation software market at $17 billion in 2020, with an expected rise to $30 billion by 2024, the company said its \"fully automated enterprise\" software gives it a current market opportunity of more than $60 billion.CEO holds most of the cardsSince 2015, UiPath has raised about $2 billion in eight funding rounds, according to Crunchbase. That funding doesn't appear to have bought much voting power in the company, though.UiPath's Class B shares carry 35 votes, while Class A shares -- being offered in the IPO -- carry one vote. The S-1 filing revealed that CEO Dines holds 100% of the Class B shares and 6.5% of the Class A shares, for 88.1% of the voting power.The only entity that comes close to that is venture-capital firm Accel, which began building its stake in 2017, and now claims about 101 million Class A shares, or 24% of those shares, for 3.1% of the voting power. Earlybird Management, with 9.5% of Class A shares, commands 1.2% of the votes.The company has reined in expensesFor the fiscal year 2021 ended Jan. 30, the company booked $607.6 million in revenue for a loss of $92.4 million, compared with $336.2 million in revenue for a loss of $519.9 million in fiscal 2020. In 2018, UiPath reported fiscal 2019 revenue of $148.5 million and a loss of $261.6 million.As revenue rose 81% for fiscal 2021, UiPath reduced sales and marketing costs by 21%, research and development costs by 16%, and general and administrative expenses by 10%.No specific plans for the fundsIf underwriters exercise all option for shares in the offering, UiPath expects to bring in net proceeds of about $1.34 billion, based on a $56 stock price. With about $357.7 million in ready cash on the books as of Jan. 31, the company isn't earmarking raised capital for any specific use.\"As of the date of this prospectus, we cannot specify with certainty all of the particular uses for the net proceeds to us from this offering,\" the company said in its April 19 filing. \"However, we currently intend to use the net proceeds we receive from this offering for general corporate purposes, including working capital, operating expenses, and capital expenditures.\"COVID-19 boosted diverse customer baseAs of Jan. 31, the company claimed having nearly 8,000 customers, with 63% of the those in the Fortune Global 500. About 1,000 of those customers account for more than $100,000 in ARR apiece, UiPath said. The company highlighted such customers as Adobe Inc. $(ADBE)$, Applied Materials Inc. $(AMAT)$, Chevron Corp. $(CVX)$, Chipotle Mexican Grill Inc. $(CMG)$, CrowdStrike Holdings Inc. $(CRWD)$, CVS Health Corp. $(CVS)$ and Uber Technologies Inc. $(UBER)$.That's compared with the 700-or-so customers the company claimed in 2018.The company's current customer base is spread out enough where one customer can't upset revenue significantly.  \"No customer or channel partner accounted for more than 10% of our revenue for the year-ended January 31, 2021,\" according to the S-1.Meanwhile, the COVID-19 pandemic helped. On Jan. 31, 2020, the company said it had about 6,000 customers, so during the year of the pandemic alone, UiPath grew its number of customers by 33%.\"As the pandemic persisted, global demand for automation continued to accelerate as automation became essential for business execution and performance in a remote working environment,\" UiPath said.\"While the pandemic may have accelerated the adoption of automation, the need for organizations to address extraordinary cost pressures, preserve and grow revenue, and adapt to ever-evolving end-customer needs illustrates the durability of the demand for digital transformation and the resilience and power of automation in even the most challenging times,\" according to the company.","news_type":1},"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":202844441149656,"gmtCreate":1690551847184,"gmtModify":1690551850067,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ </a>&nbsp;where can ger tigers gpt information?&nbsp;","listText":"<a href=\"https://ttm.financial/S/TIGR\">$Tiger Brokers(TIGR)$ </a>&nbsp;where can ger tigers gpt information?&nbsp;","text":"$Tiger Brokers(TIGR)$ where can ger tigers gpt information?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/202844441149656","isVote":1,"tweetType":1,"viewCount":795,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3563421686188310","authorId":"3563421686188310","name":"Hopehope赋予希望","avatar":"https://community-static.tradeup.com/news/46495f44529967f5d3b4d03a47167f5b","crmLevel":9,"crmLevelSwitch":1,"idStr":"3563421686188310","authorIdStr":"3563421686188310"},"content":"go to search button on the top right. then a tiger gpt app will appear at bottom right","text":"go to search button on the top right. then a tiger gpt app will appear at bottom right","html":"go to search button on the top right. then a tiger gpt app will appear at bottom right"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":837573412,"gmtCreate":1629902233736,"gmtModify":1676530168048,"author":{"id":"3581823025693276","authorId":"3581823025693276","name":"YungKhai","avatar":"https://static.tigerbbs.com/4a5f4e885c0d10a9adf1c049adec48f2","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581823025693276","authorIdStr":"3581823025693276"},"themes":[],"htmlText":"When FDA approve?&nbsp;","listText":"When FDA approve?&nbsp;","text":"When FDA approve?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/837573412","repostId":"1160914293","repostType":4,"repost":{"id":"1160914293","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1629901886,"share":"https://ttm.financial/m/news/1160914293?lang=&edition=fundamental","pubTime":"2021-08-25 22:31","market":"us","language":"en","title":"Novavax stock surged 5% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1160914293","media":"Tiger Newspress","summary":"Novavax stock surged 5% in morning trading.Novavax to participate in octave-duo study to evaluate th","content":"<p>Novavax stock surged 5% in morning trading.Novavax to participate in octave-duo study to evaluate third dose of vaccine in participants with impaired immune systems;Novavax' recombinant nanoparticle protein vaccine candidate is being studied in octave-duo, now underway in UK.</p>\n<p><img src=\"https://static.tigerbbs.com/8ba4406a459a8630f805b4239180530c\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax stock surged 5% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax stock surged 5% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-25 22:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax stock surged 5% in morning trading.Novavax to participate in octave-duo study to evaluate third dose of vaccine in participants with impaired immune systems;Novavax' recombinant nanoparticle protein vaccine candidate is being studied in octave-duo, now underway in UK.</p>\n<p><img src=\"https://static.tigerbbs.com/8ba4406a459a8630f805b4239180530c\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160914293","content_text":"Novavax stock surged 5% in morning trading.Novavax to participate in octave-duo study to evaluate third dose of vaccine in participants with impaired immune systems;Novavax' recombinant nanoparticle protein vaccine candidate is being studied in octave-duo, now underway in UK.","news_type":1},"isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}